- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
June 18, 2013
AVAC and the Harm Reduction Coalition organized a teleconference to discuss the recent results of the Bangkok Tenofovir Study, a Thai trial of pre-exposure prophylaxis in injecting drug users.
Presentations were followed by a Q&A session. Questions unanswered during the webinar are addressed in a supporting document, available here.
Also worth checking out, Beyond the Hype: PrEP for people who inject drugs by Daniel Wolfe.
Location
Webinar
Speakers
Michael Martin
US Centers for Disease Control
Dawn Smith
US Centers for Disease Control
Daniel Raymond
Harm Reduction Coalition